Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

NCT04033419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Decline
Chemo-brain

Interventions

DRUG: Memantine

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]